Arca
Skip to content

Diasys Integra Ii

System, Measurement, Blood-Pressure, Non-Invasive. 510(k) K042109, from Novacor France (Rueil Malmaison Cedex, FR). Product code DXN, class 2.

As of Nov 17, 2026, K042109 is an FDA 510(k) held by Novacor France, substantially equivalent on Mar 9, 2005 after 216 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Mar 9, 2005
  • Review time: 216 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Diasys Integra II is a non-invasive Ambulatory Blood Pressure (ABP) recorder. It measures the systolic, diastolic, mean blood pressure (BP) and the heart rate (HR). It measures and records the patient position and the arterial rigidity (QKd) at the time of each BP measurement.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other DXN Clearances

The newest 510(k)s for the same product code; their median review was 231 days; see every DXN device

Record

Type
Traditional
Received
Aug 5, 2004
Review panel
Cardiovascular
Regulation
21 CFR 870.1130

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.